Saad Javed

1.1k total citations
20 papers, 808 citations indexed

About

Saad Javed is a scholar working on Physiology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Saad Javed has authored 20 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Neurology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Saad Javed's work include Pain Mechanisms and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Pharmacology and Obesity Treatment (4 papers). Saad Javed is often cited by papers focused on Pain Mechanisms and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Pharmacology and Obesity Treatment (4 papers). Saad Javed collaborates with scholars based in United Kingdom, Qatar and United States. Saad Javed's co-authors include Rayaz A. Malik, Uazman Alam, Ioannis N. Petropoulos, Gregory Y.H. Lip, Dhiraj Gupta, Mitra Tavakoli, Georgios Ponirakis, Albert Dahan, Anthony Cerami and Shazli Azmi and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Diabetic Medicine.

In The Last Decade

Saad Javed

18 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saad Javed United Kingdom 13 433 273 138 104 92 20 808
Ann M. Poynten Australia 18 569 1.3× 154 0.6× 222 1.6× 208 2.0× 119 1.3× 52 1.1k
Jan B. Groener Germany 19 345 0.8× 214 0.8× 180 1.3× 56 0.5× 20 0.2× 37 802
Christos Manes Greece 11 702 1.6× 494 1.8× 657 4.8× 69 0.7× 76 0.8× 15 1.5k
Cinzia D’Amato Italy 15 390 0.9× 258 0.9× 134 1.0× 19 0.2× 33 0.4× 23 836
Rahul Yadav India 12 321 0.7× 141 0.5× 221 1.6× 36 0.3× 18 0.2× 43 836
Özkan Ateş Türkiye 18 158 0.4× 414 1.5× 37 0.3× 49 0.5× 36 0.4× 82 1.1k
Amro Stino United States 11 236 0.5× 263 1.0× 75 0.5× 18 0.2× 16 0.2× 36 627
Simon E.M Eaton United Kingdom 6 917 2.1× 614 2.2× 653 4.7× 57 0.5× 91 1.0× 8 1.8k
Helena Schmid Brazil 18 219 0.5× 64 0.2× 271 2.0× 59 0.6× 28 0.3× 48 903
Edward J. Bastyr United States 22 576 1.3× 360 1.3× 1.1k 7.6× 49 0.5× 72 0.8× 27 1.9k

Countries citing papers authored by Saad Javed

Since Specialization
Citations

This map shows the geographic impact of Saad Javed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saad Javed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saad Javed more than expected).

Fields of papers citing papers by Saad Javed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saad Javed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saad Javed. The network helps show where Saad Javed may publish in the future.

Co-authorship network of co-authors of Saad Javed

This figure shows the co-authorship network connecting the top 25 collaborators of Saad Javed. A scholar is included among the top collaborators of Saad Javed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saad Javed. Saad Javed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Javed, Saad, et al.. (2025). Efficacy and Safety of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta‐Analysis. Journal of Clinical Hypertension. 27(9). e70155–e70155.
2.
Hammersley, Daniel, Saad Javed, John Gregson, et al.. (2024). Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission. European Journal of Heart Failure. 27(1). 113–123. 5 indexed citations
3.
Hammersley, Daniel, Saad Javed, Saibal Mukhopadhyay, et al.. (2024). Long-term follow-up of the TRED-HF trial. European Heart Journal. 45(Supplement_1).
4.
Javed, Saad & Brian P. Halliday. (2023). Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift?. SHILAP Revista de lepidopterología. 1. e34–e34. 2 indexed citations
5.
Javed, Saad, et al.. (2021). Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot.. Journal of Geriatric Cardiology. 18(4). 297–306. 2 indexed citations
6.
Vitolo, Marco, Saad Javed, Davide Capodanno, et al.. (2020). Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis. Expert Review of Cardiovascular Therapy. 18(9). 587–600. 6 indexed citations
7.
Burgess, Jamie, Saad Javed, Bernhard Frank, Rayaz A. Malik, & Uazman Alam. (2020). Mirogabalin besylate in the treatment of neuropathic pain. Drugs of today. 56(2). 135–135. 16 indexed citations
8.
Javed, Saad, Dhiraj Gupta, & Gregory Y.H. Lip. (2020). Obesity and atrial fibrillation: making inroads through fat. European Heart Journal - Cardiovascular Pharmacotherapy. 7(1). 59–67. 43 indexed citations
9.
Javed, Saad, et al.. (2019). Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabetic Medicine. 37(4). 573–579. 40 indexed citations
10.
Kumar, Mohit, Adam Chapman, Saad Javed, et al.. (2018). The Investigation and Treatment of Diabetic Gastroparesis. Clinical Therapeutics. 40(6). 850–861. 42 indexed citations
11.
Javed, Saad, Uazman Alam, & Rayaz A. Malik. (2018). Mirogabalin and emerging therapies for diabetic neuropathy. Journal of Pain Research. Volume 11. 1559–1566. 28 indexed citations
12.
Alam, Uazman, et al.. (2016). Vitamin D and Diabetic Complications: True or False Prophet?. Diabetes Therapy. 7(1). 11–26. 42 indexed citations
13.
Petropoulos, Ioannis N., Saad Javed, Shazli Azmi, et al.. (2016). Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa (MENA) region: Much work needs to be done. Journal of Taibah University Medical Sciences. 11(4). 284–294. 13 indexed citations
14.
Javed, Saad, Uazman Alam, & Rayaz A. Malik. (2015). Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions. The Review of Diabetic Studies. 12(1-2). 63–83. 70 indexed citations
15.
Kass‐Iliyya, Lewis, Saad Javed, David Gosal, et al.. (2015). Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study. Parkinsonism & Related Disorders. 21(12). 1454–1460. 116 indexed citations
16.
Javed, Saad, Uazman Alam, & Rayaz A. Malik. (2015). Burning through the pain: treatments for diabetic neuropathy. Diabetes Obesity and Metabolism. 17(12). 1115–1125. 52 indexed citations
17.
Ponirakis, Georgios, Hassan Fadavi, Ioannis N. Petropoulos, et al.. (2015). Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy. Journal of Diabetes Research. 2015. 1–7. 21 indexed citations
18.
Brines, Michael, Ann Dunne, Monique van Velzen, et al.. (2014). ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes. Molecular Medicine. 20(1). 658–666. 116 indexed citations
19.
Javed, Saad, Ioannis N. Petropoulos, Mitra Tavakoli, & Rayaz A. Malik. (2014). Clinical and diagnostic features of small fiber damage in diabetic polyneuropathy. Handbook of clinical neurology. 126. 275–290. 11 indexed citations
20.
Javed, Saad, Ioannis N. Petropoulos, Uazman Alam, & Rayaz A. Malik. (2014). Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease. 6(1). 15–28. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026